Enjoy complimentary customisation on priority with our Enterprise License!
The global gastrointestinal diseases therapeutics market size is estimated to grow by USD 18.52 billion at a CAGR of 6.81% between 2023 and 2028. Companies in the global gastrointestinal diseases therapeutics market are mainly emphasizing the development of new therapeutics for the treatment of various gastrointestinal-related diseases. Increasing spending on R&D by pharmaceutical and biopharmaceutical companies has supported the development of advanced therapeutics for gastrointestinal diseases. An upsurge in the number of new product launches and product approvals for gastrointestinal disease therapeutics is driving the growth of the gastrointestinal (GI) diseases therapeutics market. For instance, In July 2020, the FDA approved AvsolaTM (Infliximab-axxq) blocker for the treatment of adult and pediatric patients with moderately to severely active Crohn's disease, as well as individuals with moderately to severely active ulcerative colitis who had an insufficient response to traditional therapy. Therefore, new product launches of gastrointestinal disease therapeutics will drive the growth of the market growth during the forecast period.
To learn more about this report, Request Free Sample
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Drug Class
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.